Endo's New Chief Has Challenges Ahead
As Firm's US Generics Sales Continue To Suffer
Set to take charge of the company on 6 March, Endo's incoming chief Blaise Coleman must tackle Endo's multi-billion-dollar debt and steer the firm back to profitability after several years of significant losses.
